Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project
Copyright policy )Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project
AbstractBackgroundGuideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project aimed to standardize medical practice using quality indicators (QIs) as indices to evaluate the quality of medical practice. In this study, we have reported the quality indicator values of prescription before the beginning of the guideline lectures in the EGUIDE project to ascertain the baseline status of treating patients with schizophrenia.MethodsA cross‐sectional, retrospective case record survey was conducted, involving 1164 patients with schizophrenia at the time of discharge. We checked all types and dosage of psychotropic drugs.ResultsForty‐three percent of patients had antipsychotic polypharmacy, and substantial concomitant medication was observed (antidepressants; 8%, mood stabilizers: 37%, anxiolytics or hypnotics: 68%).ConclusionsIn the results obtained in this study, we plant to report changes in the effectiveness of education in the EGUIDE project near the future.
- Japan Community Healthcare Organization Japan
- Osaka University Japan
- University of Tokyo Japan
- Kyoto University Japan
- Tohoku University Japan
Male, Micro Reports, Neurosciences. Biological psychiatry. Neuropsychiatry, RM1-950, Japan, Surveys and Questionnaires, Humans, quality indicator, Practice Patterns, Physicians', Quality Indicators, Health Care, Retrospective Studies, Psychiatry, Antidepressive Agents, schizophrenia, antipsychotics, Cross-Sectional Studies, Prescriptions, Anti-Anxiety Agents, EGUIDE project, Practice Guidelines as Topic, Polypharmacy, Schizophrenia, Female, Therapeutics. Pharmacology, guideline, RC321-571, Antipsychotic Agents
Male, Micro Reports, Neurosciences. Biological psychiatry. Neuropsychiatry, RM1-950, Japan, Surveys and Questionnaires, Humans, quality indicator, Practice Patterns, Physicians', Quality Indicators, Health Care, Retrospective Studies, Psychiatry, Antidepressive Agents, schizophrenia, antipsychotics, Cross-Sectional Studies, Prescriptions, Anti-Anxiety Agents, EGUIDE project, Practice Guidelines as Topic, Polypharmacy, Schizophrenia, Female, Therapeutics. Pharmacology, guideline, RC321-571, Antipsychotic Agents
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).44 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!